FTC probing J & amp;J over arthritis drug Remicade
The organization issued a civil investigative demand to the drugmaker to see if its biosimilar defense strategy violates federal antitrust laws. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 30, 2019 Category: Pharmaceuticals Source Type: news
New painkiller that seemed destined for greatness may only get limited FDA nod
One of the buzziest new painkillers in trials for the last few years has been Pfizer and Ely Lilly ’s tanezumab, a nerve growth factor drug. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 29, 2019 Category: Pharmaceuticals Source Type: news
Potential Novartis blockbuster misses the mark in new study
Novartis ’ Entresto already has the potential to hit $3 billion in sales for its current heart failure indication, and with another indication in mind, the company hoped sales could hit $5 billion. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 29, 2019 Category: Pharmaceuticals Source Type: news
Novartis CEO says he won't sell Sandoz unit
Novartis CEO Vas Narasimhan pledged in a published interview that the Swiss drugmaker will not sell its generics unit amid a revamp that has prompted rumors about offloading Sandoz. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 29, 2019 Category: Pharmaceuticals Source Type: news
Pfizer to combine off-patent drug business with Mylan
Pfizer has agreed to merge its off-patent drugs business with generic drugmaker Mylan. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 29, 2019 Category: Pharmaceuticals Source Type: news
Merck to build new plant in N.C.
Merck Sharp and Dohme will invest some $680 million in new manufacturing space and expanded packaging space to support its HPV vaccine Gardisil. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 26, 2019 Category: Pharmaceuticals Source Type: news
Vertex names new CEO
Vertex Pharmaceuticals announced that its chief medical officer, Reshma Kewalramani, will take over as president and chief executive in April 2020. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 26, 2019 Category: Pharmaceuticals Source Type: news
Pharma in review: trending stories 7/26/19
Most popular Pharma Manufacturing stories from the past seven days. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 26, 2019 Category: Pharmaceuticals Source Type: news
Humira biosim wins FDA approval
The clock is ticking on how much longer the world ’s best-selling drug will be free from biosimilar competition in the U.S. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 24, 2019 Category: Pharmaceuticals Source Type: news
GSK hires new chairman as it prepares for split
GlaxoSmithKline has hired a former finance chief from Novartis and AstraZeneca as its new non-executive chairman. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 24, 2019 Category: Pharmaceuticals Source Type: news
Bayer recalls two lots of mislabeled hemophilia A med
The drugmaker is voluntarily recalling two lots that were filled with factor VIII hemophilia A treatment Jivi but were labeled as containing hemophilia treatment Kogenate FS (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 23, 2019 Category: Pharmaceuticals Source Type: news
Sanofi makes deal for Tamiflu rights from Roche
The deal will give Sanofi exclusive OTC rights to the flu treatment in the U.S. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 23, 2019 Category: Pharmaceuticals Source Type: news
10 of the highest-paid CEOs in pharma
Lucrative compensation packages for CEOs are certainly not unique to pharma. But many of the industry ' s top dogs got hefty raises last year, showing it ' s a good time to be a CEO in pharma. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 22, 2019 Category: Pharmaceuticals Source Type: news
Pfizer ’s Lyrica officially drops off the patent cliff
It was great while it lasted. But Pfizer ’s blockbuster drug, Lyrica, is now officially facing generics competition. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 22, 2019 Category: Pharmaceuticals Source Type: news
FDA rejects Biohaven treatment for Lou Gehrig ’s disease
Biohaven Pharmaceutical Holding Co. has reported that its new treatment for armyotrophic lateral sclerosis, or Lou Gehrig ’s disease, has failed to win FDA approval. (Source: PharmaManufacturing.com)
Source: PharmaManufacturing.com - July 22, 2019 Category: Pharmaceuticals Source Type: news
